(HealthDay News) — Long-term melatonin use for treatment of insomnia is associated with a higher risk for incident heart failure and all-cause mortality, according to a study to be presented at the ...

Findings showed fenebrutinib significantly reduced relapses vs teriflunomide in RMS and was noninferior to ocrelizumab in slowing disability progression in PPMS. Topline data were announced from two ...

A phase 3 trial evaluating a nebulized clofazimine inhalation suspension (MNKD-101) for the treatment of refractory nontuberculous mycobacterial (NTM) ...

(HealthDay News) — A peanut patch treatment ( Viaskin Peanut Patch; [VP250]) continues to help toddlers safely build tolerance to peanuts over 3 years, according to a study presented at the annual ...

Two major drugmakers will slash the price of popular weight loss medications for some Americans, including people on Medicare and Medicaid, President Donald Tru ...

The approval for HR-SMM was based on data from the phase 3 AQUILA study, which evaluated Darzalex Faspro in adults aged 31 years and older with HR-SMM.

The Food and Drug Administration (FDA) has approved Linzess ® (linaclotide) for the treatment of irritable bowel syndrome with constipation (IBS-C) in patients 7 years of age and older. Previously, ...

HealthDay News — A first-of-its-kind clinical trial is beginning in the US to see if pig kidneys could help save the lives of people waiting for a human organ transplant.

The Food and Drug Administration (FDA) has approved Caplyta ® (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder (MDD) in adults.

HealthDay News — Serial adjunctive ketamine infusions are not more effective than serial midazolam infusions in reducing depressive symptoms in patients receiving inpatient psychiatric care for a ...

HealthDay News — The Maldives has become the first country in the world to ban tobacco use for an entire generation, after a new law took effect Saturday.

The FDA is expected to decide on treatments for asthma, chronic rhinosinusitis with nasal polyps, dyslipidemia, Cushing syndrome, gonorrhea, HSCT-associated thrombotic microangiopathy, marginal zone ...